Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Taro Pharmaceuticals...

    Taro Pharmaceuticals recalls over 7.7 thousand tubes of Fluocinonide cream from US

    Written by Ruby Khatun Khatun Published On 2017-05-25T13:34:53+05:30  |  Updated On 25 May 2017 1:34 PM IST
    Taro Pharmaceuticals recalls over 7.7 thousand tubes of Fluocinonide cream from US

    New Delhi: Domestic drug major Sun Pharma's arm Taro Pharmaceuticals USA, Inc is recalling over 7.7 thousand tubes of Fluocinonide cream, used for treatment of various skin conditions, from the American market.


    Taro Pharmaceuticals USA Inc is recalling 7,776 tubes of Fluocinonide cream, 0.05 per cent due to cross contamination with other products, the United States Food and Drug Administration (USFDA) said in its latest Enforcement Report.


    Reason for recall is "cross contamination with other products: certain lots of Fluocinonide cream were found to be contaminated with a small quantity of hydrocortisone-17- valerate", it added.


    Fluocinonide cream is used for treating inflammation and itching caused by psoriasis, atopic dermatitis, and certain other skin conditions.


    The voluntary ongoing nationwide recall is a class III recall, the report said.


    As per the USFDA, a class III recall is initiated in "a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences".

    atopic dermatitisCross ContaminationFluocinonide creamhydrocortisone-17- valerateinflammationitchingPsoriasisrecallSun PharmaceuticalsTaro PharmaceuticalsUSFDA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok